Loading insider details...
Latest Form 4 (Jun 24, 2026): Disposition to Issuer of 147,954 CNTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Centessa Pharmaceuticals plc (CNTA) | Disposition to Issuer | 147,954 | n/a |
| Feb 3, 2026 | Centessa Pharmaceuticals plc (CNTA) | Tax Withholding | 8,549 | $210.0K |
| Nov 18, 2025 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 40,000 | $376.8K |
| Nov 13, 2025 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 40,000 | $376.8K |
| Sep 24, 2025 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 35,000 | $329.7K |
| Sep 11, 2025 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 24,792 | $198.6K |
| Feb 4, 2025 | Centessa Pharmaceuticals plc (CNTA) | Tax Withholding | 8,693 | $147.1K |
| Dec 31, 2024 | Centessa Pharmaceuticals plc (CNTA) | Tax Withholding | 6,419 | $105.0K |
| Dec 17, 2024 | Centessa Pharmaceuticals plc (CNTA) | Sale | 9,611 | $157.3K |
| Oct 2, 2024 | Centessa Pharmaceuticals plc (CNTA) | Tax Withholding | 6,419 | $101.4K |